Stanford Patent Found Invalid in IPR proceedings but Licensee’s IP Survives

By Tom Engellenner In a decision this month (IPR2013-00308), the Patent Trial and Appeal Board (PTAB) has ruled against Stanford University’s patented method for detecting Down’s syndrome and other chromosomal defects, finding all of the challenged claims 1-13 invalid. The Stanford patent, U.S. Patent Number 8,296,076, is licensed to Verinata Health Inc., and is the … Continue reading Stanford Patent Found Invalid in IPR proceedings but Licensee’s IP Survives